Abstract: A multi-modality medical system having a computing system communicatively coupled to a medical instrument is provided. An acquisition control activity module is configured to control acquisition of medical data from a patient with the medical instrument and a business logic state machine having a first data acquisition state and a first data review state and being operable to utilize the acquisition control activity module to control acquisition of medical data from the patient with the medical instrument while in the first data acquisition state, and being configured to convert the medical data into images representative of portions of the patient while in the first data acquisition state. The computing system includes also includes a user interface state machine having a second data acquisition state and a second data review state and being configured to present the images within a user interface while in the second data review state.

Abstract: The invention relates to methods for phenotyping by determining protein activity in vivo using at least one probe compound and enhancing the nuclear polarisation of NMR active nuclei present in the probe compound (hereinafter termed “hyperpolarisation”) prior to NMR analysis.

Abstract: The invention relates to methods for determining protein activity using NMR spectroscopy. The present invention provides a method for determining protein activity in vivo using probe compounds and enhancing the nuclear polarisation of NMR active nuclei present in the probe compounds (hereinafter termed “hyperpolarisation”) prior to NMR analysis. The invention also provides mixtures of probe compounds for the above-mentioned method.